Does lamotrigine cause sexual dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lamotrigine and Sexual Dysfunction

Lamotrigine can cause sexual dysfunction, but the evidence shows it produces paradoxical effects—both sexual dysfunction AND hypersexuality—depending on the individual patient. The available evidence suggests lamotrigine is more likely to improve sexual function or cause hypersexuality than to cause traditional sexual dysfunction, though both outcomes are documented.

Evidence for Sexual Dysfunction

The clearest case of lamotrigine-induced sexual dysfunction comes from a 56-year-old male patient who experienced dose-dependent sexual problems including complete loss of libido, impotence, anejaculation, and anorgasmia at 300 mg daily 1. This patient demonstrated a clear temporal relationship: sexual function partially returned after 48 hours off medication and further improved at 72 hours, though this led to seizure auras. This pattern of periodic non-adherence persisted for 12 months specifically due to sexual side effects.

A 2023 case report documented lamotrigine-induced Persistent Genital Arousal Disorder (PGAD) in a patient with major depressive disorder and PTSD, which improved with sertraline treatment 2.

Evidence for Hypersexuality and Improved Function

Conversely, two male patients developed acute hypersexuality while taking lamotrigine as add-on therapy—one with carbamazepine, one with oxcarbazepine 3. In the first case, hypersexuality resolved after discontinuing lamotrigine; in the second, dose reduction decreased intensity while maintaining improved sexual satisfaction. Neither patient had prior psychiatric illness or brain damage predisposing them to this response.

A 2006 review noted that lamotrigine may help improve sexual dysfunction in epilepsy patients, potentially through reduction of seizures, inhibition of focal discharges, or unknown effects on reproductive hormones 4.

Clinical Context

The key distinction is that lamotrigine is NOT listed among the psychotropic drugs most commonly associated with sexual dysfunction. Guidelines specifically identify that "most psychotropic drugs can affect libido or erectile function" through direct action or by increasing prolactin or decreasing testosterone 5. However, lamotrigine is notably absent from these lists, which instead emphasize:

  • Antidepressants (particularly serotonergic agents)
  • Antihypertensives (especially diuretics and beta-blockers, except nebivolol)
  • Drugs that block androgen receptors (spironolactone, cimetidine, flutamide)
  • Drugs that decrease testosterone production (ketoconazole, aminoglutethimide)

Practical Management Algorithm

If a patient on lamotrigine reports sexual dysfunction:

  1. Establish temporal relationship: Did symptoms begin or worsen after starting/increasing lamotrigine? Sexual dysfunction is present in 40-70% of epilepsy patients baseline 1, 6, so distinguishing pre-existing from treatment-emergent dysfunction is critical.

  2. Assess dose-dependency: The documented case showed clear dose-response at 300 mg daily with improvement at lower doses or drug holidays 1.

  3. Rule out other causes: Review all concurrent medications (antidepressants, antihypertensives), comorbid conditions (depression, diabetes, hypertension), and relationship factors before attributing dysfunction to lamotrigine.

  4. Consider trial dose reduction: If seizure control permits, reduce lamotrigine dose to assess whether sexual function improves while maintaining therapeutic efficacy.

  5. If dysfunction persists despite dose reduction: Switch to alternative antiepileptic with more favorable sexual profile (oxcarbazepine has documented benefit for carbamazepine-induced dysfunction 4).

Critical Caveats

  • Bidirectional screening is essential: Clinicians must proactively ask about sexual function, as patients rarely volunteer this information spontaneously, leading to silent non-adherence 1, 6.

  • Gender differences exist: Most documented cases involve male patients; data on female sexual dysfunction with lamotrigine is limited.

  • Mechanism remains unclear: Unlike other psychotropics, lamotrigine's mechanism for sexual effects (whether dysfunction or hypersexuality) is not well-characterized and does not appear to involve typical prolactin elevation or testosterone suppression 3.

  • Non-adherence risk: Sexual dysfunction is a key driver of antiepileptic drug non-adherence, with potentially serious consequences for seizure control 1, 6.

Bottom line: While lamotrigine CAN cause sexual dysfunction in susceptible individuals, it is not among the primary offenders and may paradoxically improve sexual function in some patients. When sexual dysfunction occurs, establish causality through temporal relationship and dose-response before discontinuing an otherwise effective medication.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.